 Wall Street jumped on Wednesday as Gilead Sciences gave an encouraging update on a potential COVID-19 treatment and upbeat earnings from Google-parent Alphabet boosted shares of other technology and internet giants. Gilead rose 4.8 after the drugmaker said its experimental antiviral drug remdesivir 